5.40Open5.40Pre Close0 Volume7 Open Interest165.00Strike Price0.00Turnover732.18%IV123.01%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry5.40Extrinsic Value100Contract SizeAmericanOptions Type0.2325Delta0.0056Gamma14.15Leverage Ratio-2.3783Theta0.0012Rho3.29Eff Leverage0.0226Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet